AI assistant
LISATA THERAPEUTICS, INC. — Director's Dealing 2011
Jul 1, 2011
34931_dirs_2011-07-01_c3bbc0db-13a5-4400-b1d1-50e15f0825b6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-06-29
Reporting Person: Talamo Joseph (See Remarks)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-06-29 | Stock Option (right to purchase) | $1.43 | A | 325000 | Acquired | 2011-06-28 | Common Stock (325000) | Direct |
Footnotes
F1: On June 29, 2011, the commencement date (the "Commencement Date") of his employment with NeoStem, Inc. (the "Company"), the
reporting person was granted an option to purchase 325,000 shares of the Company's common stock, par value $0.001 per share
(the "Common Stock"), pursuant and subject to the terms and conditions of the Company's 2009 Equity Compensation Plan. This
option vested as to 25,000 shares on the Commencement Date, and is scheduled to vest as to 50,000 shares on each of December
29, 2011 and June 29, 2012, and as to 100,000 shares on each of June 29, 2013 and June 29, 2014, provided that the reporting
person remains employed by the Company on each of such dates.